Monoclonal gammopathy of increasing significance: time to screen?

Monoclonal gammopathy (MG) is a frequently detected clonal B-cell or plasma-cell disorder. Importantly, every multiple myeloma (MM) case is preceded by MG. Although clinical algorithms now allow earlier treatment of patients with biomarkers of malignancy before MM-induced tissue damage (CRAB) occurs...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lucia Y., Drayson, Mark, Bunce, Christopher, Ramasamy, Karthik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Perspective Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233333/
https://www.ncbi.nlm.nih.gov/pubmed/36373250
http://dx.doi.org/10.3324/haematol.2022.281802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233333/
https://www.ncbi.nlm.nih.gov/pubmed/36373250
http://dx.doi.org/10.3324/haematol.2022.281802

Ejemplares similares